Uxolo Pharma Llp - Due diligence report
A 360° intelligence report on Uxolo Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signa…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Uxolo Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsUxolo Pharma Llp is assessed as Low Risk with a Trust Score of 88/100. Uxolo Pharma Llp is an active limited liability partnership incorporated in 2020, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 13 Oct 2026 from the latest processed filings. Uxolo Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- No balance-sheet filing date on record.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KUNHI PARAMBATH LUBAID | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAMEER KUNHI PARAMBIL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 3 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Steepleware Solutions Private Limited | U72200TN2005PTC055387 | Chennai, Tamil Nadu |
| Struct House India Private Limited | U45309TN2019PTC131756 | Chennai, Tamil Nadu |
| Cranecare Private Limited | U52602TN2021PTC142823 | Chennai, Tamil Nadu |
| Dynamic Leather Wholesaler Private Limited | U51909TN2021PTC147410 | Chennai, Tamil Nadu |
| Skywalkers Infotech Private Limited | U72200TN2007PTC062478 | Chennai, Tamil Nadu |
| Arkitin Private Limited | U72900TN2022PTC155597 | Chennai, Tamil Nadu |
| One-Man Services (Opc) Private Limited | U52100TN2022OPC149926 | Chennai, Tamil Nadu |
| Lightbeam Projects Private Limited | U74999TN2018PTC122581 | Chennai, Tamil Nadu |
| Focuzcloud Technology Private Limited | U72900TN2012PTC085896 | Chennai, Tamil Nadu |
| VENKATARAMANA MINERALS LLP | AAX-1570 | Chennai, Tamil Nadu |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Uxolo Pharma Llp before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Uxolo Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Uxolo Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Uxolo Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Uxolo Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Uxolo Pharma Llp an active company?
Uxolo Pharma Llp has MCA status “Active” with a compliance score of 90/100 (Low Risk).
Is Uxolo Pharma Llp financially healthy?
Processed financial statements are not yet available for Uxolo Pharma Llp, so its financial health is unassessed.
Should I do business with Uxolo Pharma Llp?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Uxolo Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Uxolo Pharma Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Uxolo Pharma Llp up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).
Is it risky to lend to Uxolo Pharma Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.